The Globe and Mail, August 31, 1999, reprinted a report from the Wall Street Journal prepared by Elyse Tanouye with the headline " Schizophrenia. A Bold New Therapy for the Madness that Ruins Families." I began to read this report with great interest thinking that perhaps there was something very bold, innovative and even therapeutic for this difficult disease. It turns out that what is being proposed is neither new, nor bold and certainly will not, be therapeutic. The Yale Psychiatric Institute's Prime Research Clinic in New Haven proposes that young patients with an increased risk for schizophrenia may benefit from a promising but highly unorthodox experimental treatment. They hope that giving anti-psychotic drugs along with conventional talk therapy can interrupt the biological processes. They hope they can prevent the development of schizophrenia.